Advertisement

Chronisch-entzündliche Darmerkrankungen und Dickdarmkrebs

Conference paper

Zusammenfassung

Die erhöhte Krebsgefährdung von Patienten mit chronisch-entzündlichen Darmerkrankungen ist allgemein bekannt. Sie hat Eingang in die Lehrbücher gefunden und ist im Gegenstandskatalog des Instituts für Medizinische und Pharmazeutische Prüfungsfragen aufgeführt. Die pauschale Feststellung ist in dieser Form jedoch nicht akzeptabel und bedarf verschiedener Differenzierungen. Diese betreffen:
  1. 1)

    die Ausdehnung der Colitis,

     
  2. 2)

    die Dauer der Erkrankung,

     
  3. 3)

    die Schwere der Erkrankung,

     
  4. 4)

    die Unterscheidung in Colitis ulcerosa und M. Crohn,

     
  5. 5)

    das Auftreten von Dysplasien in der Schleimhaut.

     

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Blackstone M, Riddell RH, Rogers B, Levin B (1981) Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long standing ulcerative colitis:an indication for colectomy. Gastroenterology 80:306–374Google Scholar
  2. Boland CR, Lance P, Levin B, Riddell RH, Kim YS (1984) Abnormal goblet cell glycoconjugates in rectal biopsies associated with an increased risk of neoplasia in patients with ulcerative colitis:Early results of a prospective study. Gut 25:1364–1371PubMedCrossRefGoogle Scholar
  3. Butt JH, Lennard-Jones JE, Ritchie JK (1980) A practical approach to the cancer risk in inflammatory bowel disease. Med Clin N Am 64:1203–1220PubMedGoogle Scholar
  4. Butt JH, Koniski F, Morson BC, Lennard-Jones JE, Ritchie J (1983) Macroscopic lesions in dysplasia complicating ulcerative colitis. Dig Dis Sci 28:18–26PubMedCrossRefGoogle Scholar
  5. Collins RH, Feldman M, Fordtran JS (1987) Colon cancer, dysplasia and surveillance in patients with ulcerative colitis. A critical review. N Engl J Med 316:1654–1658PubMedCrossRefGoogle Scholar
  6. De Dombal F, Watts J, Watkinson G, Goligher J (1966) Lokal complications of ulcerative colitis:stricture, pseudopolyposis and carcinoma of colon and rectum. Br Med J 1:1442–1447PubMedCrossRefGoogle Scholar
  7. Devroede GI, Taylor WF, Sauer WG, Jackman RI, Stickler GB (1971) Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med 285:17–21PubMedCrossRefGoogle Scholar
  8. Dobbins WO (1984) Dysplasia and malignancy in inflammatory bowel disease. Am Rev Med 35:33–48CrossRefGoogle Scholar
  9. Gilat T, Freman A, Groosman A et al. (1988) Colorectal cancer in patients with ulcerative colitis. A population study in central Israel. Gastroenterology 94:870–877PubMedGoogle Scholar
  10. Greenstein AJ, Sachar DB, Smith H et al. (1979) Cancer in universal and left-sided ulcerative colitis:factors determining risk. Gastroenterology 77:290–294PubMedGoogle Scholar
  11. Gyde SN, Prior P, Allan RN et al. (1988) Colorectal cancer in ulcerative colitis:a cohort study of primary referrals from three centres. Gut 29:206–217PubMedCrossRefGoogle Scholar
  12. Hammarberg C, Rubio C, Slezak P, Tribukait B, Öhman U (1984) Flow-cytometric DNA analysis as a mean for early detection of malignancy in patients with ulcerative colitis. Gut 25:905–908PubMedCrossRefGoogle Scholar
  13. Johnson W, McDermott F, Hughas E, Pihl E, Mike E, Price EA (1983) Carcinoma of the colon and rectum in inflammatory bowel disease of the intestine. Surg Gyn Obstet 156:193–197Google Scholar
  14. Katzka I, Brody RS, Morris E, Katz S (1983) Assessment of colorectal cancer risk in patients with ulcerative colitis:experience from a private practice. Gastroenterology 85:22–29PubMedGoogle Scholar
  15. Lennard-Jones JE (1985) Cancer risk in ulcerative colitis:surveillance of surgery. Br J Surg 72 [Suppl]:84–86CrossRefGoogle Scholar
  16. Lennard-Jones JE, Ritchie JK, Marson BC, Williams CB (1983) Cancer surveillance in ulcerative colitis. Lancet 2:149–152PubMedCrossRefGoogle Scholar
  17. Morson BC, Pang LSC (1967) Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 8:423–434PubMedCrossRefGoogle Scholar
  18. Petras RE, Mir-Madylessi SH, Farmer RG (1987) Crohn’s disease and intestinal carcinoma. A report of 11 cases with emphasis on associated epithelial dysplasia. Gastroenterology 93:1307–1314PubMedGoogle Scholar
  19. Prior P, Gyde SN, Macartney JC, Thomson H, Waterhouse JAH, Allan RN (1982) Cancer morbidity in ulcerative colitis. Gut 23:490–497PubMedCrossRefGoogle Scholar
  20. Riddell RH, Goldman H, Ransohoff DF, Appelman H (1983) Dysplasia in inflammatory bowel disease:standardised classification with provisional clinical applications. Hum Pathol 14:931–968PubMedCrossRefGoogle Scholar
  21. Riddell RH, Schmidt H, Levin B (1984) Cancer in Barrett’s esophagus and inflammatory bowel disease — what’s new. In:Levin B, Riddell RH (eds) Frontiers in gastroenterological cancer. Elsevier, New York, pp 307 — 319Google Scholar
  22. Rosenstock E, Farmer RG, Petras R, Givak MV, Rankin GB, Sulliman BH (1985) Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology 89:1342–1346PubMedGoogle Scholar
  23. Waye JD (1986) Screening for cancer in ulcerative colitis. Front Gastroent Res 10:243–256Google Scholar
  24. Whelan G (1980) Cancer risk in ulcerative colitis:why are results in the literature so varied? Clin Gastroenterol 9:469–476PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • K. Ewe

There are no affiliations available

Personalised recommendations